Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Freeze Thaws: US FDA Allowed To Hire Staff For Cures, User Fee Activity

Mar 23 2017

• By Derrick Gingery

FDA entrance sign 2016

Related Content

Rare Disease Integration Into FDA Reviews Will Grow Under PDUFA VI

Jul 18 2016

Trump's Budget Outline Threatens User Fee Agreements

Mar 17 2017

FDA User Fee Hearing Hijacked By US Health Care Reform Arguments

Mar 22 2017

A Burning FDA Hiring Freeze Question: What About User Fee-Supported Staff?

Jan 24 2017

US FDA Getting More Money Up Front Under Cures Bill Revisions

Dec 01 2016

FDA's Breakthrough Workload Will Be Eased By Hiring Reviewers With PDUFA VI Funds

Jul 21 2016

CDER’s 50 Open Leadership Posts Could Be Bigger Hiring Challenges After Trump Freeze

Feb 02 2017

US FDA May Find Relief From Trump's Hiring Freeze

Feb 02 2017

FDA Gets Broad Exemptions From Federal Hiring Freeze In HHS Memo

Feb 10 2017

The Evolution Of 21<sup>st</sup> Century Cures Legislation

Nov 30 2016

Cures Bill Authorizes 'Intercenter Institutes,' But Will US FDA Create Them?

Nov 28 2016

Additional Topics

United States FDA Legislation Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window